368 results on '"Hama, Naoki"'
Search Results
2. Laparoscopic transabdominal preperitoneal repair for a patient with Laugier’s and inguinal hernia
3. Induced pluripotent stem cell–derived hematopoietic stem and progenitor cells induce mixed chimerism and donor-specific allograft tolerance
4. Perioperative fluid management influences complication rates and length of hospital stay in the enhanced recovery after surgery (ERAS) protocol for patients with colorectal cancer
5. An aggressive gastric CIC-DUX4 sarcoma surgically resected with multivisceral organs: a case report.
6. Coexistence of multiple liver metastases from sigmoid colon cancer and a gastrointestinal stromal tumor in the small intestine
7. A case of intraductal papillary mucinous neoplasm developing in the native pancreas after pancreas transplantation treated by total pancreatectomy
8. The clinical impact of splenic artery ligation on the occurrence of digestive varices after pancreaticoduodenectomy with combined portal vein resection: a retrospective study in two institutes
9. Retrograde endoscopic submucosal dissection for early thoracic esophageal carcinoma
10. Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade
11. Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine and nanoparticle albumin-bound paclitaxel combination therapy as neoadjuvant chemotherapy for resectable/borderline resectable pancreatic ductal adenocarcinoma (PDAC-GS/GA-rP2, CSGO-HBP-015)
12. 276 CAR-T cell effector function is prolonged by controlling JNK activation
13. CA19-9 level determines therapeutic modality in pancreatic cancer patients with para-aortic lymph node metastasis
14. Prognostic impact of nodal statuses in patients with pancreatic ductal adenocarcinoma
15. Bromodomain-containing protein 4 regulates interleukin-34 expression in mouse ovarian cancer cells
16. iPSC-derived hematopoietic stem and progenitor cells induce mixed chimerism and donor-specific allograft tolerance
17. Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer
18. Safety and Feasibility of Laparoscopic Pelvic Exenteration for Locally Advanced or Recurrent Colorectal Cancer
19. Interleukin-34 cancels anti-tumor immunity by PARP inhibitor
20. Successful conversion surgery for unresectable pancreatic cancer with peritoneal metastases after neoadjuvant albumin-bound paclitaxel and gemcitabine chemotherapy: case report and literature review
21. Safety and efficacy of an enhanced recovery after surgery protocol for elderly patients undergoing colorectal surgery
22. Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy
23. Pulmonary metastasectomy for metachronous metastasis of esophageal cancer after esophagectomy
24. Postoperative Changes in Body Composition After Pancreaticoduodenectomy Using Multifrequency Bioelectrical Impedance Analysis
25. Prevalence of Malnutrition Among Gastric Cancer Patients Undergoing Gastrectomy and Optimal Preoperative Nutritional Support for Preventing Surgical Site Infections
26. Perioperative fluid management influences complication rates and length of hospital stay in the enhanced recovery after surgery (ERAS) protocol for patients with colorectal cancer
27. Clinical significance of surgical resection of metastatic lymph nodes from hepatocellular carcinoma
28. Implications of peritoneal lavage cytology in resectable left-sided pancreatic cancer
29. Reprogramming Using microRNA-302 Improves Drug Sensitivity in Hepatocellular Carcinoma Cells
30. Interleukin-34 expression in ovarian cancer : a possible correlation with disease progression
31. A Case of Recurrent Pancreatic Head Neuroendocrine Carcinoma Presented with Ectopic Acth Syndrome
32. Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade
33. Gastric conduit-preserving, radical pancreaticoduodenectomy with microvascular reconstruction for pancreatic head cancer after esophagectomy: report of a case
34. A phase I trial of combination therapy using gemcitabine and S-1 concurrent with full-dose radiation for resectable pancreatic cancer
35. Evaluation of safety parameters and changes in serum concentration in liver transplant recipients treated with doxorubicin during the anhepatic period
36. PTK787/ZK222584 Combined with Interferon Alpha and 5-Fluorouracil Synergistically Inhibits VEGF Signaling Pathway in Hepatocellular Carcinoma
37. Survival Impact of Pulmonary Metastasis as Recurrence of Pancreatic Ductal Adenocarcinoma
38. National Survey of Hepatobiliary and Pancreatic Surgery in Hemophilia Patients in Japan
39. BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer
40. Intrahepatic cholangiocarcinoma in a worker at an offset color proof-printing company: An autopsy case report
41. Clinical utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in predicting World Health Organization grade in pancreatic neuroendocrine tumors
42. Prognostic impact of tumoral and/or peri-tumoral stromal SPARC expressions after surgery in patients with biliary tract cancer
43. Five Simultaneous Multiple Intussusceptions Due to Cutaneous Malignant Melanoma: A Case Report
44. P3-1 The experience of nivolumab therapy in the patients with advanced and recurrence gastric cancer
45. Randomized Phase II Study of Gemcitabine and S-1 Combination Therapy Versus Gemcitabine and Nanoparticle Albumin-Bound Paclitaxel Combination Therapy in Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC-GS/GA-rP2, CSGO-HBP-015)
46. An optimized protocol for patient-derived xenograft in humanized mice to evaluate the role of IL-34 in immunotherapeutic resistance
47. INTERFERON-α AND 5-FLUOROURACIL COMBINATION THERAPY FOLLOWING HEPATIC RESECTION FOR ADVANCED HEPATOCELLULAR CARCINOMA WITH PORTAL VENOUS TUMOR THROMBUS: FO24–05
48. A Case of Remnant Stomach Bleeding after Distal Gastrectomy Treated with Transcatheter Arterial Embolization and with Conservative Improvement of Secondary Remnant Gastric Ischemia
49. Predicting the necessity of autologous blood collection and storage before surgery for hepatocellular carcinoma
50. Plasma miR-21 is a novel diagnostic biomarker for biliary tract cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.